Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of INX-08189 in treatment-naïve adults chronically infected with hepatitis C (Genot…
-
CLINICAL_TRIALS trial_result · 2012-07-04Clinical Trial Update: A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects [Phase 1]
Phase 1 trial in healthy subjects comparing the relative bioavailability of three new telaprevir formulations.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy [Phase 3]
Phase 3 trial evaluating the efficacy of daily-dose consensus interferon plus ribavirin for chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive [Phase 3]
A Phase 3 trial comparing viramidine to ribavirin in treatment-naive patients with chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive [Phase 3]
Phase 3 study comparing Viramidine to Ribavirin in treatment-naive patients with chronic hepatitis C has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C [Phase 2]
A Phase 2 viral kinetic study of Viramidine in therapy-naive patients with chronic hepatitis C has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C [Phase 2, Phase 3]
Clinical trial update comparing BIP48 (peginterferon alfa-2b 48 kDa) with Pegasys (peginterferon alfa-2a 40 kDa) for chronic hepatitis C in …
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 study of the anti-CTLA-4 monoclonal antibody CP-675,206 for advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Open-Label Hepatic Impairment Study [Phase 1]
An open-label Phase 1 hepatic impairment study sponsored by Gilead Sciences for Hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-08Clinical Trial Update: Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed [Phase 2]
A Phase 2 trial assessed the safety and immunomodulatory effects of SCV 07 as a monotherapy or in combination with ribavirin in noncirrhotic…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C [Phase 2]
This Phase 2 trial compared the oral thrombopoietin receptor agonist SB497115 to placebo in adults with thrombocytopenia due to chronic hepa…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults [Phase 1]
A Phase 1 trial comparing monotherapy to placebo in healthy adults and adults with chronic hepatitis C was terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection [Phase 2]
A Phase 2 study evaluating the efficacy and safety of GS-9256 and GS-9190, alone and with ribavirin, over 28 days in chronic hepatitis C pat…
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Kaletra Monotherapy in HIV/HCV Co-infected Subjects [Phase 3]
Phase 3 trial evaluating Kaletra monotherapy in HIV/Hepatitis C co-infected subjects has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders [Phase 2]
Phase 2 trial evaluating standard of care with or without CTS-1027 in hepatitis C patients who did not respond to prior therapy; the study w…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV [NA]
This clinical trial update reports on the completion of a study comparing Acoustic Radiation Force Impulse imaging with Transient Elastograp…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Treatment of Recurrent Hepatitis C After Liver Transplantation [Phase 3]
A Phase 3 clinical trial evaluating treatment for recurrent Hepatitis C after liver transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease [Phase 3]
Phase 3 trial of eltrombopag to initiate and maintain interferon antiviral therapy for patients with chronic hepatitis C-related liver disea…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis C [Phase 4]
Phase 4 trial assessing the efficacy and effectiveness of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C; th…
-
CLINICAL_TRIALS research · 2012-05-10Clinical Trial Update: A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.
This clinical trial update describes a five-year observational follow-up to characterize real-world treatment patterns for Hepatitis C in Ch…
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients [Phase 2]
A Phase 2 two-week dosing trial of LCQ908 in Hepatitis C patients assessing safety and antiviral activity; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance. [Phase 4]
A Phase 4 study evaluated peginterferon alfa-2a plus ribavirin with or without pioglitazone in treatment-naive patients with chronic hepatit…
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C [Phase 3]
The completed Phase 3 trial evaluated Viusid, an antioxidant and immunomodulator, in patients with chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections [Phase 1]
Phase 1 trial evaluating the safety and preliminary effectiveness of a two-drug combination in patients co-infected with hepatitis C and adv…
-
CLINICAL_TRIALS withdrawal · 2012-04-25Clinical Trial Update: Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis C [Phase 2]
A Phase 2 trial evaluating an angiotensin receptor blocker as an anti-fibrotic treatment for chronic Hepatitis C was withdrawn from the stud…